26Jun
Financial Daily Dose 6.25.2019 | Top Story: Allergan and AbbVie Combine Forces in $63 Billion Deal
Massive pharma news to start the day, with AbbVie announcing that it’s reached a deal to buy Allergan for roughly $63 billion. The tie-up is seen as giving AbbVie a “dominant position in the $8 billion-plus market for Botox and other beauty drugs” is...
By:
Robins Kaplan LLP
Related
This November, Californians may get the chance to vote on a ballot measure that would address some o...
Read More >
A precedent-setting criminal prosecution of two California executives under the Consumer Product Saf...
Read More >
Employers must carefully navigate Family and Medical Leave Act (“FMLA”) pitfalls when administerin...
Read More >
In a regime undergoing rapid change, investment screening is currently "light," with red tape increa...
Read More >
On July 15, 2019, Rhode Island’s Governor signed into law the Rhode Island Noncompetition Agreement...
Read More >
Nous vous proposons, dans cette newsletter, de revenir sur les nouvelles règles applicables au détac...
Read More >